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‘Tis as impossible that he’s undrown’d
as he that sleeps here swims.
The Tempest, 2.2
S
ystematic reviews, which synthesize data from 
individual studies, are considered the highest level 
of evidence for evaluating the effectiveness of health 
care interventions. They inform clinical practice guide-
lines and are used by health policy-makers to guide key 
decision-making. They can point to gaps in knowledge 
that need to be filled by new research, and identify areas 
where, because of a saturation of evidence about effective-
ness, new research is not needed and might even be un-
ethical.1 On 22 February 2011, the Centre for Reviews and 
Dissemination at the University of York launched PROS-
PERO, an international prospective register of systematic 
review protocols. The registry was developed to address 
the excessive duplication of systematic reviews, improve 
transparency and minimize reporting biases. Open Medi-
cine endorses systematic review protocol registration at 
PROSPERO and encourages prospective authors to regis-
ter their review protocols on health care interventions at 
www.metaxis.com/PROSPERO/.
One recent study estimated that 11 new systematic re-
views are published every day.2 There is currently sub-
stantive  duplication  of  specific  topics  among  reviews, 
each of which might have slightly varied methods and 
quality.3 Although replication of research is an important 
aspect of the scientific method, unnecessary duplication 
may result in the waste of academic resources without 
bringing us closer to the truth. This duplication is also 
an ineffective use of taxpayer dollars, particularly when 
such reviews are funded by public agencies. If adopted 
widely, PROSPERO will allow review authors to quickly 
familiarize  themselves  with  ongoing  reviews  so  that 
they can avoid duplication. Policy-makers will be better 
able  to  identify  those  questions  regarding  health  care 
effectiveness that require urgent investigation, as distinct 
from those that are already under way. Funders can also 
use the register to help identify instances of excessive 
duplication. PROSPERO may serve to increase the visi-
bility of a particular review and potentially foster collab-
oration among various groups. Such collaboration could 
also expand a review group’s ability to assess evidence 
published in languages other than English.  
The plethora of reviews being produced is known to 
be of variable quality.4 In 2009, a PRISMA (Preferred 
Reporting  Items  for  Systematic  Reviews  and  Meta- 
Analyses)  statement  called  for  improved  transparency 
in the reporting of systematic reviews through the regis-
tration of systematic review protocols: such registration 
could reduce the probability of selective reporting bias-
es.5  Synthesis  methods  such  as  systematic  review  and 
meta-analysis were originally developed to reduce bias in 
assessing the treatment effect of a particular health care 
intervention.  These  approaches  work  on  the  condition 
that acceptable methods of searching and appraising the 
evidence are undertaken.  
However, a number of studies have found that publi-
cation bias and selective reporting biases threaten the 
validity of some systematic reviews.6–9 In the context of 
systematic  reviews,  selective  outcome  reporting  arises 
when  the  specific  outcomes  that  the  reviewer  chooses 
to describe do not match those specified in the review 
protocol,  or  their  level  of  importance  does  not  match 
that specified in the protocol (e.g., primary, secondary).6 
Kirkham and colleagues7 compared published Cochrane 
systematic  reviews  to  their  protocols  and  found  that 
22% (64/288) had a discrepancy in at least one outcome 
measure and that 75% of these discrepancies were attrib-
utable to changes in the primary outcome. The changes 
were sometimes made after the results of the individual 
trials were known.7 In fact, other research indicates that 
selective  outcome  reporting  bias  in  systematic  reviews 
may be underestimated. Kirkham and colleagues8 found 
that outcome reporting bias was suspected in at least one 
randomized controlled trial in over one-third (96) of the 
283 Cochrane systematic reviews they examined in detail. 
Among the 81 reviews that included a single meta-analysis 
of  a  primary  outcome,  the  sensitivity  analysis  revealed 
that the selective outcome reporting bias overestimated 
the treatment effect estimates by 20% in about 23% of the 
meta-analyses.8 This compounding of bias means that au-
thors of systematic reviews must be scrupulously careful 
and transparent.
Despite  the  knowledge  that  completed  reviews  fre-
quently deviate from their protocols, to date most system-
atic reviews do not have publicly accessible protocols. The PROSPERO registry allows editors, peer reviewers and 
other stakeholders to better assess the methods reported 
in the systematic review and to examine whether the re-
view deviated from the original protocol and why. One can 
also review the methods used to minimize these biases, 
given that the information would be far more transparent. 
From  the  journal  editor’s  perspective,  the  data  ele-
ments for systematic review protocol registration provide 
enhanced transparency and increase the probability that 
credible evidence will be published. A competing interest 
statement would help editors, peer reviewers and readers 
consider whether conflict of interest might have affected 
the methods and interpretation of results. A publicly ac-
cessible systematic review protocol registry would also 
improve  reproducibility,  in  that  any  protocol  changes 
would be documented and a rationale provided. In our 
current environment of proprietary ownership of health 
care knowledge, PROSPERO can only be a first, albeit 
crucial,  step  in  improving  the  quality  of  synthesis  re-
search. PROSPERO will act as an open repository of data 
provided by those authors who chose to register, and will 
be important for all of the reasons described here.
One substantial limitation to PROSPERO’s ability to 
ensure transparency between the protocol and the final 
review is the fact that, even if the protocol is accessible, 
the final review will not be unless it is published, opti-
mally, in an Open Access journal or made freely access-
ible in the more traditional closed-access journals. Open 
Medicine will continue to engage the scientific commun-
ity in committing to the ongoing improvement of trans-
parency in health care research (see Box 1).
Second,  PROSPERO  currently  supports  protocol 
registration for formal systematic reviews of health care 
interventions, whereas we know that other knowledge 
syntheses  such  as  scoping  and  rapid  reviews  are  also 
populating the published and grey literature and may 
equally require scrutiny of their methodological clarity 
and transparency.10,11
Finally, PROSPERO cannot act as a watchdog in the 
systematic review community, and we recognize that well 
conducted systematic reviews are immensely time-con-
suming endeavours. Given the importance of systematic 
reviews  in  clinical  and  health  policy  decision-making, 
protocol  registration  should  be  mandated  by  funding 
bodies and, in future, by scholarly journals to enhance 
the transparent reporting of systematic reviews.
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Box 1: Building on PROSPERO
•  Encourage authors to concurrently submit a PRISMA checklist and 
fl  ow diagram.
•  Encourage authors to share their study inclusion and risk of bias 
(quality) assessment tools, with the ultimate aim of streamlining 
the way reviews are performed.
•  Encourage (1) the free availability of systematic reviews, so that 
they can be read and compared by stakeholders to protocols 
registered with PROSPERO, or (2) their Open Access publication, 
so that their contents can be shared, copied and used to make 
derivative works, including other systematic reviews.
•  Consider novel ways of publishing systematic reviews, such as wiki 
platforms, in order to experiment with ways of keeping reviews 
current and open to scrutiny.12